Tag: Pharma

Envision Pharma Group (Envision), a leading global technology-enabled strategic solutions partner for the life sciences industry, unveils its AI Innovation Board and announces the appointment of Dr. Loubna Bouarfa as AI thought leader and Chairwoman of the newly established board. This strategic move underscores Envision’s global commitment to harnessing the power of AI to shape the future of the life sciences industry. Previously serving as the CEO and founder of OKRA.ai, which was acquired by Envision in February 2023, Dr. Bouarfa revolutionized healthcare by creating AI systems that support life sciences companies to better enable the drive of personalized medicine ... Read more

 India-based Alventa Pharma, a leading third party manufacturing pharma, is excited to announce the launch of their cost-effective generic drugs in both domestic and international markets. Alongside being Third party manufacturing pharma, Alventa Pharma now expands its services as a contract manufacturer, operating from its state-of-the-art facility in Baddi. Driven by a commitment to enhance access to high-quality healthcare, Alventa Pharma manufactures and supplies generic drugs while creating opportunities for PCD pharma franchise in India. The company’s focus on meeting the demands of the Indian and Asian markets has led to the development of a wide range of generic drugs. ... Read more

Envision Pharma Group (Envision) today announced the appointment of Dr. Deepti Sodhi Jaggi to the Envision Board of Directors. “We are pleased to welcome Deepti to the Envision Board of Directors,” shares Meg Heim, CEO of Envision Pharma Group. “Deepti’s deep experience in the technology of Artificial Intelligence (AI) and digital therapeutics in the life sciences industry will be invaluable to our mission at Envision as we continue to accelerate our global business expansion and commitment to our clients, and most importantly, impacting patient lives in a positive manner.” Dr. Jaggi’s career includes over 20 years of experience in driving ... Read more

Envision Pharma Group (Envision) has appointed Richard “Rich” Gorman to the role of President, Strategic Consulting and member of the Executive Leadership Team. Rich is a 30-year veteran of the life sciences industry and a respected leader with a track record of success in pharmaceutical commercialization. He is an experienced head of high-performing teams that build go-to-market strategies to deliver on business development and revenue generation goals. Rich will be responsible for leading the Strategic Consulting business across Envision’s commercial, medical, and technology sectors. He will lead a team of scientific, medical, and commercial strategists with deep expertise in the ... Read more

Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore’s biologics manufacturing capabilities. BioPIPS MOU signing ceremony Their partnership will be formalised through the Biologics Pharma Innovation Programme Singapore (BioPIPS), a consortium initiated by A*STAR with support from the Singapore Economic Development Board (EDB). BioPIPS seeks to use research and innovation to grow Singapore’s manufacturing capabilities for biologics, which include recombinant therapeutic ... Read more